What is the share price of Sunil Healthcare Ltd (SUNLOC) today?
The share price of SUNLOC as on 11th July 2025 is ₹82.99. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Sunil Healthcare Ltd (SUNLOC) share?
The past returns of Sunil Healthcare Ltd (SUNLOC) share are- Past 1 week: -2.77%
- Past 1 month: 3.25%
- Past 3 months: 13.84%
- Past 6 months: 3.74%
- Past 1 year: -11.73%
- Past 3 years: 17.13%
- Past 5 years: 317.04%
What are the peers or stocks similar to Sunil Healthcare Ltd (SUNLOC)?
The peers or stocks similar to Sunil Healthcare Ltd (SUNLOC) include:What is the market cap of Sunil Healthcare Ltd (SUNLOC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sunil Healthcare Ltd (SUNLOC) is ₹85.10 Cr as of 11th July 2025.What is the 52 week high and low of Sunil Healthcare Ltd (SUNLOC) share?
The 52-week high of Sunil Healthcare Ltd (SUNLOC) is ₹104 and the 52-week low is ₹60.55.What is the PE and PB ratio of Sunil Healthcare Ltd (SUNLOC) stock?
The P/E (price-to-earnings) ratio of Sunil Healthcare Ltd (SUNLOC) is -60.36. The P/B (price-to-book) ratio is 1.22.Which sector does Sunil Healthcare Ltd (SUNLOC) belong to?
Sunil Healthcare Ltd (SUNLOC) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Sunil Healthcare Ltd (SUNLOC) shares?
You can directly buy Sunil Healthcare Ltd (SUNLOC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Sunil Healthcare Ltd
SUNLOC Share Price
82.991.62% (+1.32)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SUNLOC Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SUNLOC Performance & Key Metrics
SUNLOC Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -59.93 | 1.22 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.68 | 6.41 | 0.79% |
SUNLOC Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SUNLOC Company Profile
Sunil Healthcare Limited is engaged in manufacturing hard gelatin capsule shells and food products. The Company is engaged in market survey and supply chain establishment by markets its products under the Sunloc Foods brand name.
SUNPHARMA
PE Ratio
36.71
36.71
1Y Return
5.71%
5.71%
Buy Reco %
87.10
87.10
CIPLA
PE Ratio
22.75
22.75
1Y Return
1.39%
1.39%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
58.69
58.69
1Y Return
12.03%
12.03%
Buy Reco %
70.83
70.83
MANKIND
PE Ratio
53.44
53.44
1Y Return
21.78%
21.78%
Buy Reco %
81.25
81.25
DRREDDY
PE Ratio
18.46
18.46
1Y Return
4.87%
4.87%
Buy Reco %
50.00
50.00
SUNLOC Forecast
SUNLOC Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SUNLOC
SUNLOC
Income
Balance Sheet
Cash Flow
Annual Normal View
SUNLOC Income Statement
SUNLOC Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 109.85 | 93.56 | 81.06 | 84.70 | 96.20 | 120.84 | 114.99 | 95.41 | 84.76 | 84.75 | ||||||||||
Raw Materials | 49.45 | 36.64 | 35.00 | 35.48 | 32.71 | 43.30 | 50.01 | 46.98 | 73.16 | 73.15 | ||||||||||
| Power & Fuel Cost | 6.87 | 8.89 | 9.53 | 9.27 | 8.39 | 8.90 | 9.35 | 9.04 | ||||||||||||
| Employee Cost | 10.67 | 12.57 | 12.57 | 13.02 | 12.30 | 14.25 | 14.79 | 13.06 | ||||||||||||
| Selling & Administrative Expenses | 7.02 | 7.98 | 8.05 | 8.02 | 8.64 | 11.81 | 10.02 | 6.50 | ||||||||||||
| Operating & Other expenses | 19.44 | 11.36 | 4.46 | 11.43 | 23.29 | 23.52 | 10.15 | 10.52 | ||||||||||||
EBITDA | 16.40 | 16.12 | 11.45 | 7.48 | 10.87 | 19.06 | 20.67 | 9.31 | 11.60 | 11.60 | ||||||||||
| Depreciation/Amortization | 4.33 | 4.78 | 5.74 | 6.13 | 6.11 | 6.31 | 7.01 | 6.09 | 6.35 | 6.36 | ||||||||||
| PBIT | 12.07 | 11.34 | 5.71 | 1.35 | 4.76 | 12.75 | 13.66 | 3.22 | 5.25 | 5.24 | ||||||||||
| Interest & Other Items | 4.18 | 5.03 | 6.58 | 6.95 | 5.31 | 3.49 | 4.17 | 5.78 | 6.46 | 6.46 | ||||||||||
| PBT | 7.89 | 6.31 | -0.87 | -5.60 | -0.55 | 9.26 | 9.49 | -2.56 | -1.21 | -1.22 | ||||||||||
| Taxes & Other Items | 2.86 | 1.81 | -0.18 | -0.63 | 0.09 | 2.84 | 2.80 | -0.77 | 0.20 | 0.20 | ||||||||||
| Net Income | 5.03 | 4.50 | -0.69 | -4.97 | -0.64 | 6.42 | 6.69 | -1.79 | -1.41 | -1.42 | ||||||||||
| EPS | 4.91 | 4.39 | -0.67 | -4.85 | -0.62 | 6.26 | 6.52 | -1.75 | -1.38 | -1.38 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SUNLOC Company Updates
SUNLOC Stock Peers
SUNLOC Past Performance & Peer Comparison
SUNLOC Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sunil Healthcare Ltd | -60.36 | 1.22 | — |
| Sun Pharmaceutical Industries Ltd | 36.71 | 5.53 | 0.96% |
| Cipla Ltd | 22.75 | 3.83 | 1.08% |
| Torrent Pharmaceuticals Ltd | 58.69 | 14.78 | 0.18% |
SUNLOC Stock Price Comparison
Compare SUNLOC with any stock or ETFCompare SUNLOC with any stock or ETF
SUNLOC
SUNLOC Holdings
SUNLOC Shareholdings
SUNLOC Promoter Holdings Trend
SUNLOC Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
SUNLOC Institutional Holdings Trend
SUNLOC Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SUNLOC Shareholding Pattern
SUNLOC Shareholding Pattern
SUNLOC Shareholding History
SUNLOC Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing SUNLOC stock
smallcases containing SUNLOC stock
Looks like this stock is not in any smallcase yet.
SUNLOC Events
SUNLOC Events
SUNLOC Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SUNLOC has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SUNLOC Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SUNLOC has not given any dividends in last 5 years
SUNLOC Dividends
SUNLOC Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSUNLOC Stock News & Opinions
SUNLOC Stock News & Opinions
Articles & Videos
Earnings
Sunil Healthcare consolidated net profit rises 140.00% in the March 2025 quarter
Net profit of Sunil Healthcare rose 140.00% to Rs 0.36 crore in the quarter ended March 2025 as against Rs 0.15 crore during the previous quarter ended March 2024. Sales declined 0.52% to Rs 21.20 crore in the quarter ended March 2025 as against Rs 21.31 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 1.42 crore in the year ended March 2025 as against net loss of Rs 1.79 crore during the previous year ended March 2024. Sales declined 7.51% to Rs 83.42 crore in the year ended March 2025 as against Rs 90.19 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales21.2021.31 -1 83.4290.19 -8 OPM %14.2912.58 -12.304.53 - PBDT1.961.60 23 5.143.53 46 PBT0.280.17 65 -1.22-2.56 52 NP0.360.15 140 -1.42-1.79 21 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Sunil Healthcare to conduct board meeting
Sunil Healthcare will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Sunil Healthcare to convene board meeting
Sunil Healthcare will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Sunil Healthcare reports consolidated net loss of Rs 0.55 crore in the September 2024 quarter
Net Loss of Sunil Healthcare reported to Rs 0.55 crore in the quarter ended September 2024 as against net loss of Rs 1.10 crore during the previous quarter ended September 2023. Sales declined 14.51% to Rs 20.26 crore in the quarter ended September 2024 as against Rs 23.70 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales20.2623.70 -15 OPM %11.405.15 - PBDT0.990.13 662 PBT-0.51-1.46 65 NP-0.55-1.10 50 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Sunil Healthcare to announce Quarterly Result
Sunil Healthcare will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Sunil Healthcare to conduct AGM
Sunil Healthcare announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Sunil Healthcare to conduct AGM
Sunil Healthcare announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Sunil Healthcare reports consolidated net loss of Rs 0.69 crore in the June 2024 quarter
Net Loss of Sunil Healthcare reported to Rs 0.69 crore in the quarter ended June 2024 as against net loss of Rs 0.64 crore during the previous quarter ended June 2023. Sales declined 4.49% to Rs 21.50 crore in the quarter ended June 2024 as against Rs 22.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales21.5022.51 -4 OPM %10.283.64 - PBDT0.840.74 14 PBT-0.65-0.87 25 NP-0.69-0.64 -8 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Sunil Healthcare to table results
Sunil Healthcare will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 0.01%, vs industry avg of 10.1%
Over the last 5 years, market share decreased from 0.03% to 0.02%